Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery. (2015)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bcp.12715
PubMed Identifier: 26138622
Publication URI: http://europepmc.org/abstract/MED/26138622
Type: Journal Article/Review
Volume: 80
Parent Publication: British journal of clinical pharmacology
Issue: 5
ISSN: 0306-5251